ADRX Announces Retirement of Chief Scientific Officer
FORT LAUDERDALE, Fla., Aug 28, 2001 (BUSINESS WIRE) -- Andrx Corporation --
Andrx Group (Nasdaq:ADRX) today announced that Chih-Ming Chen, Ph.D. has
resigned from his positions as the Company's Chief Scientific Officer and as
President of Andrx Pharmaceuticals, Inc. effective immediately. Dr. Chen will
remain as Co-Chairman of the Andrx Board of Directors and will continue to work
as a consultant to the Company.
Alan P. Cohen, Andrx's Co-Chairman and Chief Executive Officer, commented:
"Chih-Ming's contributions to Andrx's success cannot be overstated, and we will
miss him. Yet, having announced my own intention to retire some months ago, I
understand and respect Chih-Ming's desire to pursue other interests. And, while
I am confident Chih-Ming has solidified our scientific team, his continued
involvement with Andrx will better ensure the smooth continuation of our
development efforts." |
